Couch, Tyler <br/><br/>
Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation.  [electronic resource] 

 -  Experimental hematology  06 2019 
 - 19-24.e4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1873-2399 
<br/><br/><label>Standard No.: </label>10.1016/j.exphem.2019.04.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CRISPR-Cas Systems<br/>Cell Culture Techniques--economics<br/>Cell Differentiation<br/>Cell Line, Transformed<br/>Erythroblasts--enzymology<br/>Gene Editing<br/>Humans<br/>K562 Cells<br/>Mutation<br/>Proto-Oncogene Proteins c-kit--genetics